John H. Glick

16.9k citations

113 papers · 9.7k indexed · 3 hit papers · h-index 43

Impact in

Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- HER2/EGFR in Cancer Research
Cancer Research top 0.2%
- Breast Cancer Treatment Studies

Papers in

Cancer Research 37
- Breast Cancer Treatment Studies 31
Oncology 53
- Cancer Treatment and Pharmacology 29

Co-authors: Richard D. Gelber Aron Goldhirsch Alan S. Coates Hans-Jörg Senn Daniel G. Haller John A. Laurie Beat Thürlimann Donna Glover
Journals: International Journal of Radiation Oncology*Biology*Physics (23 papers)Cancer (17 papers)Journal of Clinical Oncology (14 papers)JNCI Journal of the National Cancer Institute (6 papers)Annals of Oncology (5 papers)
Partner nations: United States Switzerland Italy

In The Last Decade

John H. Glick

111 papers receiving 9.2k citations

Hit Papers

align trajectories log scale

Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 2005 · 886 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 Annals of Oncology
1995 JNCI Journal of the National Cancer Institute
1990 New England Journal of Medicine

Peers

Countries citing papers authored by John H. Glick

Since Specialization

Citations

This map shows the geographic impact of John H. Glick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Glick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Glick more than expected).

Fields of papers citing papers by John H. Glick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Glick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Glick. The network helps show where John H. Glick may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John H. Glick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John H. Glick Line = papers co-authored together John H. Glick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Academy of Master Clinicians: Recognition of Clinical Excellence Within an Academic Medical Center Academic Medicine ·John H. Glick, O. O. NIKITIN, Kim M. Olthoff, Jack Ende	2017	6
2	Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Breast Clinical Breast Cancer ·Ramji R. Rajendran, Juan Palazzo, Gordon F. Schwartz, John H. Glick, Lawrence J. Solin	2008	5
3	First—select the target: better choice of adjuvant treatments for breast cancer patients Annals of Oncology ·A. Goldhirsch, Alan S. Coates, Richard D. Gelber, John H. Glick, Beat Thürlimann, H.-J. Senn	2006	82
4	Ten-year outcome after combined modality therapy for inflammatory breast cancer International Journal of Radiation OncologyBiologyPhysics ·Eleanor Harris, Delray Schultz, Helaine Bertsch, Kevin R. Fox, John H. Glick, Lawrence J. Solin	2003	89
5	Meeting highlights: International Consensus Panel on the treatment of primary breast cancer [5] (multiple letters) Journal of Clinical Oncology ·Richard R. Love, Aron Goldhirsch, John H. Glick, Richard D. Gelber, Alan S. Coates, Hans Senn	2002	2
6	Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer JNCI Journal of the National Cancer Institute ·Aron Goldhirsch, John H. Glick, Richard D. Gelber, Hans-Jörg Senn	1998	314
7	5-Fluorouracil and Leucovorin Therapy in Patients With Hormone Refractory Prostate Cancer American Journal of Clinical Oncology ·Jordan Berlin, Kathleen J. Propert, Donald L. Trump, George Wilding, Gary R. Hudes, John H. Glick, Patrick A. Burch, Alan Keller, Patrick J. Loehrer	1998	20
8	Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study. Journal of Clinical Oncology ·Joseph A. Sparano, Donna Neuberg, John H. Glick, Nicholas J. Robert, Lori J. Goldstein, George W. Sledge, Guilherme Oliveira Siqueira	1997	29
9	Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial. Journal of Clinical Oncology ·Joan H. Schiller, 高金福, Paul R. Hutson, Ronald DeVore, John H. Glick, James A. Stewart, David H. Johnson	1996	169
10	An Aggressive High Dose Cyclophosphamide and Prednisone Regimen for Advanced Multiple Myeloma Leukemia & lymphoma ·Raymond E. Lenhard, Michael J. Daniels, M. M. Oken, John H. Glick, David S. Ettinger, Leslie A. Kalish, M. J. OʼConnell	1994	6
11	The influence of young age on outcome in early stage breast cancer International Journal of Radiation OncologyBiologyPhysics ·Barbara Fowble, Delray J. Schultz, Beth Overmoyer, Lawrence J. Solin, Kevin R. Fox, Lori Jardines, Susan G. Orel, John H. Glick	1994	208
12	Adjuvant Therapy of Primary Breast Cancer: Closing Summary Recent results in cancer research ·John H. Glick, Richard D. Gelber, Aron Goldhirsch, Hans-Jörg Senn	1993	10
13	Short report: Metastatic breast cancer: Higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment Annals of Oncology ·Geoffrey Falkson, Rebecca Gelman, John H. Glick, Carla I. Falkson, James Harris	1992	5
14	Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma New England Journal of Medicine ·Leo I. Gordon, David Harrington, Janet Andersen, Joseph P. Colgan, John H. Glick, Richard S. Neiman, Risa B. Mann, Gene Resnick, Maurice Barcos, Arlan J. Gottlieb, Michael J. O’Connell	1992	260
15	Adjuvant therapy of primary breast cancer Annals of Oncology ·John H. Glick, Richard D. Gelber, Aron Goldhirsch, Hans-Jörg Senn	1992	17
16	Adjuvant combination chemotherapy cmfvp vs oophorectomy followed by cmfvp ocmfvp for premenopausal women with er positive operable breast cancer with positive axillary lymph nodes an intergroup study Breast Cancer Research and Treatment ·Saul E. Rivkin, Shiyuan Wang, Barbara Metch, Eddybrando Vásquez Núñez, 林罗发, John H. Glick, William S. Knight, C. Kent Osborne	1991	7
17	Adjuvant therapy in node-negative breast cancer Breast Cancer Research and Treatment ·William McGuire, Martin D. Abeloff, Bernard Fisher, John H. Glick, I. Craig Henderson, C. Kent Osborne	1989	24
18	Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage ii aggressive histologic type non-hodgkin's lymphoma Cancer ·Michael J. O’Connell, David P. Harrington, John D. Earle, Gerhard J. Johnson, John H. Glick, Richard S. Neiman, Murray N. Silverstein	1988	15
19	Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy Pharmacology & Therapeutics ·Donna Glover, Kevin R. Fox, Clare Weiler, Morton M. Kligerman, Andrew T. Turrisi, John H. Glick	1988	51
20	67GA scintigraphy in acute leukemia Cancer ·Michael S. Milder, John H. Glick, Edward S. Henderson, Gerald S. Johnston	1973	22

About John H. Glick

John H. Glick is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Hematology and Pulmonary and Respiratory Medicine, having authored 113 papers that have together received 9.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (31 papers), Cancer Treatment and Pharmacology (29 papers), Lymphoma Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (13 papers), Advanced Breast Cancer Therapies (12 papers), Multiple Myeloma Research and Treatments (8 papers), CNS Lymphoma Diagnosis and Treatment (7 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Oncology (5.8k citations), Cancer Research (3.1k citations), Pathology and Forensic Medicine (3.1k citations), Pulmonary and Respiratory Medicine (1.8k citations) and Hematology (599 citations). John H. Glick has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, Hans-Jörg Senn, Daniel G. Haller, John A. Laurie, Beat Thürlimann, Donna Glover, Hans-Joerg Senn and James A. Mailliard. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact